| Self-reported CHU9D Tariffs based on preferences of a youth population | Parent-reported CHU9D Tariffs based on preferences of an adult population | ||
---|---|---|---|---|
MMM (n = 197) mean ± se | MAU (n = 199) mean ± se | MMM (n = 197) mean ± se | MAU (n = 199) mean ± se | |
Baseline | 0.642 ± 0.016 | 0.631 ± 0.016 | 0.806 ± 0.009 | 0.802 ± 0.008 |
End-of-treatment (week 18) | 0.728 ± 0.016 | 0.684 ± 0.018 | 0.873 ± 0.008 | 0.844 ± 0.009 |
Follow-up (week 26) | 0.769 ± 0.015 | 0.708 ± 0.186 | 0.886 ± 0.008 | 0.839 ± 0.009 |
QALY | 0.352 ± 0.007 | 0.335 ± 0.007 | 0.426 ± 0.003 | 0.414 ± 0.004 |
Incremental QALYs | ||||
 Unadjusted | 0.017 ± 0.009 | 0.012 ± 0.005 | ||
 Adjusted for baseline | 0.014 (95% CI: 0.002–0.027) | 0.010 (95% CI: 0.004–0.016) | ||
 ICER | €210,757 /QALY gained | €291,916 /QALY gained |